These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28861330)

  • 21. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
    Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of amyloid neuropathy.
    Kapoor M; Rossor AM; Jaunmuktane Z; Lunn MPT; Reilly MM
    Pract Neurol; 2019 Jun; 19(3):250-258. PubMed ID: 30598431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary amyloidosis as a cause of microvascular angina and intermittent claudication.
    Mesquita T; Chorão M; Soares I; Mello e Silva A; Abecasis P
    Rev Port Cardiol; 2005 Dec; 24(12):1521-31. PubMed ID: 16566409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Isolated cardiac amyloidosis. Presentation of a clinical case].
    Tiberti G; Bana G; Selva A; Bossi I; Mancini R; Bossi M
    Minerva Cardioangiol; 1997 Mar; 45(3):115-9. PubMed ID: 9213819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition.
    Embry-Dierson M; Farrell MB; Schockling E; Warren J; Jerome S
    J Nucl Med Technol; 2023 Jun; 51(2):83-89. PubMed ID: 37268319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of amyloidosis and light chain deposition disease in the heart.
    Sobue Y; Takemura G; Kawamura S; Yano T; Kanamori H; Morimoto SI; Matsuo H
    Cardiovasc Pathol; 2021; 51():107315. PubMed ID: 33264681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.
    Falk RH; Alexander KM; Liao R; Dorbala S
    J Am Coll Cardiol; 2016 Sep; 68(12):1323-41. PubMed ID: 27634125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current therapeutic strategies in cardiac amyloidosis.
    Parikh S; de Lemos JA
    Curr Treat Options Cardiovasc Med; 2005 Dec; 7(6):443-8. PubMed ID: 16283971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac amyloidosis.
    Martinez-Naharro A; Hawkins PN; Fontana M
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s30-s35. PubMed ID: 29700090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and morphological diagnosis of cardiac AL amyloidosis: a review of findings and difficulties as illustrated in one case.
    Prochorec-Sobieszek M; Szufladowicz E; Szaroszyk W; Wagner T; Loukas M
    Med Sci Monit; 2005 Aug; 11(8):CS45-8. PubMed ID: 16049384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
    Cappuyns S; Verbesselt M; Van De Bruaene A; Bogaert J; Michaux L; Delforge M
    Eur Heart J Case Rep; 2022 Feb; 6(2):ytac084. PubMed ID: 35299705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloidosis: a case series and review of the literature.
    Senecal JB; Abou-Akl R; Allevato P; Mazzetti I; Hamm C; Parikh R; Woldie I
    J Med Case Rep; 2023 Apr; 17(1):184. PubMed ID: 37081462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
    Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
    Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.
    Palma JA; Gonzalez-Duarte A; Kaufmann H
    Clin Auton Res; 2019 Sep; 29(Suppl 1):33-44. PubMed ID: 31452021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH; Kinter CW; Wight J; Neelam AR; Krakow D
    J Med Case Rep; 2020 Jun; 14(1):73. PubMed ID: 32560740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment in cardiac amyloidosis.
    Kholová I; Kautzner J
    Curr Treat Options Cardiovasc Med; 2006 Dec; 8(6):468-73. PubMed ID: 17078911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.